東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back to Search results for [ null ]

Switch To: Labeled | MARC Mode | ISBD

Health promotion in the elderly: Cha...

Maharishi University of Management.

Linked to FindBook

Google Book

Amazon

博客來

Health promotion in the elderly: Changes in endocrine function after three months of modern or traditional treatment.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Health promotion in the elderly: Changes in endocrine function after three months of modern or traditional treatment./
Author:	Robinson, Donald Keith.
Description:	253 p.
Notes:	Co-Supervisors: Robert H. Schneider; Kenneth G. Walton.
Contained By:	Dissertation Abstracts International60-06B.
Subject:	Gerontology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=9933980
ISBN:	9780599347557

Health promotion in the elderly: Changes in endocrine function after three months of modern or traditional treatment.
Robinson, Donald Keith.

Health promotion in the elderly: Changes in endocrine function after three months of modern or traditional treatment. - 253 p.

Co-Supervisors: Robert H. Schneider; Kenneth G. Walton.

Thesis (Ph.D.)--Maharishi University of Management, 1999.

Research shows that improved health in older age is possible through stress reduction and modifications in lifestyle, diet and exercise. In this prospective, randomized, clinical intervention study, healthy, independent, community-dwelling elderly subjects (65 years or older) were randomly assigned to one of two health promotion programs or to a usual-care control group. The traditional health promotion program, the Maharishi Vedic Approach to Health (MVAH), included the Transcendental Meditation (TM) program and the herbal food supplement Maharishi Amrit Kalash (MAK). The modern health promotion program (MHP) included current diet and exercise practices recommended by national health organizations. Each group (n = 55) was tested at baseline and at three months for three important age- and health-related hormones: insulin-like growth factor-I (IGF-I), dehydroepiandrosterone sulfate (DHEAS), and melatonin (using the urinary metabolite 6-sulphatoxymelatonin, or 6-SM). Taking into account 60 health- and hormone-relevant outcome variables, ANCOVAs were performed on three-month pretest-to-posttest changes, comparing treatment groups and controls. There were no significant differences across groups for DHEAS and 6-SM at posttest. However, IGF-I at posttest was significantly higher in the MH (12.55 +/- 4.83P group (12.55 +/- 4.83 ng/ml change) than in the MVAH group (--5.07 +/- 5.47 ng/ml change; p = 0.019). MHP women also increased significantly in IGF-I (12.73 +/- 6.27 ng/ml change) compared to a decrease in MVAH women (--11.92 +/- 6.37 ng/mI change; p < 0.009). Omitting women on estrogen replacement therapy eliminated most treatment effects in MHP women (0.19 +/- 7.90 ng/ml change) while revealing an even larger decrease in IGF-I in the MVAH women (--16.00 +/- 7.76 ng/ml change), and a slight increase in controls (2.74 +/- 7.52 ng/ml change) (MVAH < controls, p = 0.085, trend). Associations of high-normal IGF-I levels with increased incidence of colon cancer in men, prostate cancer, breast cancer, and recurrence of breast cancer as well as decreased survival times have been reported. Thus, the significant three-month reduction of IGF-I in MVAH women may partially explain the previously reported reduced cancer mortality and cancer hospitalization associated with the TM program and MAK. The findings of high posttest IGF-I in MHP men, and the apparent enhancing effect of estrogens on IGF-I in MHP women, raise concerns about MHP practices and estrogen replacement efficacy with respect to IGF-I-related cancer risk.

ISBN: 9780599347557Subjects--Topical Terms:

533633
Gerontology.

Health promotion in the elderly: Changes in endocrine function after three months of modern or traditional treatment.
LDR:03591nam 2200301 a 45 001 857030
005 20100709
008 100709s1999 ||||||||||||||||| ||eng d
020 $a 9780599347557
035 $a (UMI)AAI9933980
035 $a AAI9933980
040 $a UMI $c UMI
100 1 $a Robinson, Donald Keith. $3 1023941
245 1 0 $a Health promotion in the elderly: Changes in endocrine function after three months of modern or traditional treatment.
300 $a 253 p.
500 $a Co-Supervisors: Robert H. Schneider; Kenneth G. Walton.
500 $a Source: Dissertation Abstracts International, Volume: 60-06, Section: B, page: 2601.
502 $a Thesis (Ph.D.)--Maharishi University of Management, 1999.
520 $a Research shows that improved health in older age is possible through stress reduction and modifications in lifestyle, diet and exercise. In this prospective, randomized, clinical intervention study, healthy, independent, community-dwelling elderly subjects (65 years or older) were randomly assigned to one of two health promotion programs or to a usual-care control group. The traditional health promotion program, the Maharishi Vedic Approach to Health (MVAH), included the Transcendental Meditation (TM) program and the herbal food supplement Maharishi Amrit Kalash (MAK). The modern health promotion program (MHP) included current diet and exercise practices recommended by national health organizations. Each group (n = 55) was tested at baseline and at three months for three important age- and health-related hormones: insulin-like growth factor-I (IGF-I), dehydroepiandrosterone sulfate (DHEAS), and melatonin (using the urinary metabolite 6-sulphatoxymelatonin, or 6-SM). Taking into account 60 health- and hormone-relevant outcome variables, ANCOVAs were performed on three-month pretest-to-posttest changes, comparing treatment groups and controls. There were no significant differences across groups for DHEAS and 6-SM at posttest. However, IGF-I at posttest was significantly higher in the MH (12.55 +/- 4.83P group (12.55 +/- 4.83 ng/ml change) than in the MVAH group (--5.07 +/- 5.47 ng/ml change; p = 0.019). MHP women also increased significantly in IGF-I (12.73 +/- 6.27 ng/ml change) compared to a decrease in MVAH women (--11.92 +/- 6.37 ng/mI change; p < 0.009). Omitting women on estrogen replacement therapy eliminated most treatment effects in MHP women (0.19 +/- 7.90 ng/ml change) while revealing an even larger decrease in IGF-I in the MVAH women (--16.00 +/- 7.76 ng/ml change), and a slight increase in controls (2.74 +/- 7.52 ng/ml change) (MVAH < controls, p = 0.085, trend). Associations of high-normal IGF-I levels with increased incidence of colon cancer in men, prostate cancer, breast cancer, and recurrence of breast cancer as well as decreased survival times have been reported. Thus, the significant three-month reduction of IGF-I in MVAH women may partially explain the previously reported reduced cancer mortality and cancer hospitalization associated with the TM program and MAK. The findings of high posttest IGF-I in MHP men, and the apparent enhancing effect of estrogens on IGF-I in MHP women, raise concerns about MHP practices and estrogen replacement efficacy with respect to IGF-I-related cancer risk.
590 $a School code: 0947.
650 4 $a Gerontology. $3 533633
650 4 $a Health Sciences, Medicine and Surgery. $3 1017756
650 4 $a Health Sciences, Public Health. $3 1017659
690 $a 0351
690 $a 0564
690 $a 0573
710 2 $a Maharishi University of Management. $3 1023940
773 0 $t Dissertation Abstracts International $g 60-06B.
790 $a 0947
790 1 0 $a Schneider, Robert H., $e advisor
790 1 0 $a Walton, Kenneth G., $e advisor
791 $a Ph.D.
792 $a 1999
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=9933980